Amgen, Inc. (AMGN)
339.57
-0.61
(-0.18%)
USD |
NASDAQ |
Apr 28, 16:00
337.74
-1.83
(-0.54%)
After-Hours: 20:00
Amgen Research and Development Expense (TTM) : 7.281B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.498B |
| Gilead Sciences, Inc. | 5.688B |
| Johnson & Johnson | 14.99B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Moderna, Inc. | 2.917B |